Form D · Other Health Care
Check-Cap Ltd
Isfiya, L3 · CIK 0001610590
Offering snapshot reported Aug 10, 2020 · SEC filing
- Reported sold
- $9.63M Offering amount: $9.63M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2020 | Initial | $9,632,534 | No comparison | 9 | SEC filing |
| May 21, 2020 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
| May 14, 2020 | Initial | $4,500,000 | No comparison | 6 | SEC filing |
| May 5, 2020 | Initial | $4,000,001 | No comparison | 8 | SEC filing |
| Nov 22, 2017 | Initial | $2,130,600 | No comparison | 4 | SEC filing |
| Jun 7, 2017 | Initial | $2,699,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $674K
- Finders' fees
- $0
- Form D file number
- 021-372819
The warrants and shares underlying the warrants, the subject matter of this Form D were issued in connection with the immediate exercise of certain warrants to purchase up to an aggregate of 16,054,223 ordinary shares.
H.C. Wainwright is also entitled to a management fee of equal to 1.0% of the proceeds of the offering, a 65,000 non-accountable expense allowance and warrants to purchase 1,123,796 ordinary shares excersiable for $0.75 for five and one-half years.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Aug 10, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Belkar | Executive |
| William Densel. | Executive |
| Clara Ezed | Director |
| Mary Jo Gorman | Director |
| Steven Hanley | Director |
| Israel Hershko | Executive |
| Tomer Kariv | Director |
| Yoav Kimchy | Executive |
| Xiang Qian (Xq) Lin | Director |
| Xiang Qian Lin | Director |
| Alex Ovadia | Executive |
| Walter Robb | Director |
| Mira Rosenzweig | Executive |
| Vardit Segal | Executive |
| Boaz Shpigelman | Executive |
| Lior Torem | Executive |
| Yuval Yanai | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
29 Abba Hushi Avenue
Isfiya, L3, 3009000
Isfiya, L3, 3009000